ExploreWatchlistsPricing
  1. JP-listed companies
  2. Alfresa Holdings Corporation
  3. Financials
  4. Property, plant and equipment, net

Alfresa Holdings Corporation (2784)

Market cap
¥463.6B
P/E ratio
12.2x
Alfresa Holdings distributes prescription drugs, medical devices, and healthcare products to serve Japan's medical industry through specialized subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndProperty, plant and equipment, net (Million JPY)YoY (%)
Mar 31, 2025192,436+5.97%
Mar 31, 2024181,601+2.70%
Mar 31, 2023176,821+8.64%
Mar 31, 2022162,758+2.40%
Mar 31, 2021158,943+4.45%
Mar 31, 2020152,178+7.53%
Mar 31, 2019141,528+3.39%
Mar 31, 2018136,886+2.77%
Mar 31, 2017133,196+2.07%
Mar 31, 2016130,489+9.87%
Mar 31, 2015118,766

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat